Yuhong Li
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 3
- RNA Research and Splicing 2
-
- Drug-Induced Hepatotoxicity and Protection 2
-
- Immune Response and Inflammation 2
- interferon and immune responses 1
- Partner nations
- ChinaUnited StatesChile
In The Last Decade
Yuhong Li
16 papers receiving 322 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 181
- Molecular Biology 225
- Clinical Biochemistry 13
- Nutrition and Dietetics 27
- Obstetrics and Gynecology 11
Countries citing papers authored by Yuhong Li
This map shows the geographic impact of Yuhong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhong Li more than expected).
Fields of papers citing papers by Yuhong Li
This network shows the impact of papers produced by Yuhong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhong Li. The network helps show where Yuhong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuhong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 47 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 4 | |
| 11 | 2018 | 17 | |
| 12 | A positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth. | 2017 | 37 |
| 13 | 2015 | 77 | |
| 14 | RAGE/NF-κB signaling mediates lipopolysaccharide induced acute lung injury in neonate rat model. | 2015 | 22 |
| 15 | 2014 | 24 | |
| 16 | 2005 | 29 | |
| 17 | 1999 | 22 |
About Yuhong Li
Yuhong Li is a scholar working on Cancer Research, Pharmacology and Immunology, having authored 17 papers that have together received 326 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Immune Response and Inflammation (2 papers), RNA Research and Splicing (2 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (181 citations), Molecular Biology (225 citations) and Clinical Biochemistry (13 citations). Yuhong Li has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Hui Zhang, Peng Gao, Ran‐Ran Ma, Haiting Liu, Xiangyi Lu, Ya‐Wen Wang, Hongfang Chen, Yanhong Feng, Xu Chen and Peng Li. Their work appears in journals such as Neuroscience & Biobehavioral Reviews, Medicine, Nano Research, Developmental Biology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.